February 06, 2013 at 08:22 AM EST
UPDATE: Deutsche Bank Initiates TESARO to Buy on Pipeline Upside
Deutsche Bank initiated TESARO (NASDAQ: TSRO ) with a Buy rating and a $27.00 price target. Deutsche Bank commented, "Tesaro is developing what we believe to be a best in class chemo-induced nausea and vomiting (CINV) drug called rolapitant. We expect phase 3 data in 2H13 to hit its
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here